InMode (NASDAQ:INMD) Rating Lowered to “Neutral” at Robert W. Baird
InMode (NASDAQ:INMD – Get Free Report) was downgraded by investment analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a report released on Monday, Marketbeat reports. They presently have a $16.00 price target on the healthcare company’s stock, down from their prior price target of $22.00. Robert W. Baird’s price […]
